Cariprazine in patients with schizophrenia – real-life data analysis based on the NEAK database (HU-NIS-CARIPRAZINE-01/2024)

Study identification

• EU PAS number:
  EUPAS1000000422
• Study ID:
  1000000422
• Official title and acronym:
  Cariprazine in patients with schizophrenia – real-life data analysis based on the NEAK database (HU-NIS-CARIPRAZINE-01/2024)
• DARWIN EU® study:
  No
• Study countries:
  Hungary
• Study status:
  Ongoing

Research institutions and networks

Institutions

Gedeon Richter

Study timelines

Date when funding contract was signed

Planned: 17/12/2024

Actual: 17/12/2024

Study start date

Planned: 01/01/2025

Actual: 05/02/2025

Date of final study report

Planned: 15/05/2025

Sources of funding

Pharmaceutical company and other private sector 

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable